EPISODE · Jul 20, 2026 · 7 MIN
今天3分钟我们来聊聊单次剂量100亿个CIK细胞，输注13次，75岁食管癌患者一年后随访肿瘤消失，恢复正常生活
from 源于细胞BioInsid的个人播客
中国食管癌发病死亡数均居世界第一，75岁高龄患者合并多种基础疾病，采用脐带血CIK细胞联合放疗治疗，肿瘤消失且生活质量显著提升，为食管癌治疗提供新方向。 参考文献： Umbilical cord blood-derived cytokine-induced killer cell infusion combined with radiotherapy for esophageal cancer: a case report. Medicine. 国家癌症中心. 2022年中国食管癌新发与死亡病例统计数据. 中国人民解放军323医院伦理委员会批准临床研究. 前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊单次剂量100亿个CIK细胞，输注13次，75岁食管癌患者一年后随访肿瘤消失，恢复正常生活
0:00
7:59
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 7 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on July 20, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!